补充立体结构脂质组合物对轻度高脂血症人群血脂干预效果的临床随机对照研究
CSTR:
作者:
作者单位:

(1.中国人民解放军总医院第一医学中心营养科,北京100853;2.扬州市妇幼保健院扬州大学附属医院临床营养科,江苏扬州 225000;3.中国人民解放军总医院第四医学中心营养科,北京100048)

作者简介:

通讯作者:

中图分类号:

基金项目:

军队保健专项科研课题(22BJZ20)


Intervention effects of supplementing a stereospecific structured lipid composition on lipid profile in patients with mild hyperlipidemia:a randomized controlled clinical trival
Author:
Affiliation:

(1.Department of Nutrition, First Medical Center, Chinese PLA General Hospital, Beijing 100853, China;2.Department of Clinical Nutrition, Affiliated Hospital of Yangzhou University, Yangzhou Maternal and Child Health Hospital, Yangzhou 225000, Jiangsu Province, China;3.Department of Nutrition, Fourth Medical Center, Chinese PLA General Hospital, Beijing 100048, China)

Fund Project:

This work was supported by the Special Scientific Research Project for MilitaryHealthcare(22BJZ20).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 观察补充立体结构脂质组合物对轻度高脂血症人群血脂及炎症水平的影响。方法 招募2024年3月至6月于解放军总医院第一医学中心门诊轻度高脂血症患者100例,采用随机、对照前瞻性研究方法,按照随机数表法随机分为立体结构脂质组合物组(干预组)和对照组,每组患者50例。干预组在低盐低脂饮食和运动指导基础上服用立体结构脂质组合物胶囊(每次3粒,每日3次),对照组常规给予低盐低脂饮食和运动指导,两组干预持续3个月。干预后比较两组间三大营养素摄入量、人体成分、血生化及超敏C-反应蛋白的影响。采用SPSS 26.0软件进行数据分析。根据数据类型,组间比较分别采用t检验、χ2检验或Fisher精确概率法。结果 共有95例患者完成研究,其中干预组患者47例,对照组患者48例。干预前,两组患者基线资料比较,差异均无统计学意义(P>0.05)。干预后,两组营养素摄入量、人体成分分析比较,差异均无统计学意义(P>0.05);两组血生化肝功能、肾功能、血糖、蛋白指标水平比较,差异均无统计学意义(P>0.05)。干预后,干预组总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、非-高密度脂蛋白胆固醇(non-HDL-C)、超敏C-反应蛋白(hs-CRP)及hs-CRP/HDL-C显著低于干预前[(4.26±1.08)和(5.79±1.12) mmol/L, (3.16±0.72)和(4.45±0.62) mmol/L, (3.05±0.82)和(3.70±0.96) mmol/L, (0.57±0.23)和(0.87±0.31) mg/dl, (0.47±0.22)和(0.67±0.25); P<0.05],对照组LDL-C显著低于干预前[(3.52±0.95)和(4.60±0.58) mmol/L; P<0.05]、而non-HDL-C显著增高[(4.78±0.63)和(3.68±1.02) mmol/L; P<0.05];干预组甘油三酯(TG)、LDL-C、non-HDL-C、hs-CRP及hs-CRP/HDL-C显著低于对照组[(1.62±1.11)和(2.21±1.32) mmol/L,(3.16±0.72)和(3.52±0.95) mmol/L,(3.05±0.82)和(4.78±0.63) mmol/L,(0.57±0.23)和(0.73±0.35) mg/dl,(0.47±0.22)和(0.64±0.36);P<0.05]。结论 轻度高脂血症人群补充立体结构脂质组合物,对肝肾功能无不利影响,能改善血脂、炎症水平,起到降低动脉粥样硬化性心血管疾病风险的作用。

    Abstract:

    Objective To observe the lipid-modulating and anti-inflammatory effects of supplementing a stereospecific structured lipid composition in patients with mild hyperlipidemia. Methods This prospective randomized controlled trial enrolled 100 patients with mild hyperlipidemia from the First Medical Center of Chinese PLA General Hospital from March to June 2024. They were randomly divided into a stereospecific structured lipid composition group (intervention group) and a control group, with 50 patients in each group. The intervention group received stereospecific structured lipid capsules (3 capsules tid) alongside standardized lifestyle modifications (low-salt, low-fat diet and exercise guidance), and the control group received only lifestyle modifications. The intervention lasted for three months in both groups. After the intervention, the intake of the three major nutrients, body composition, blood biochemistry, and high-sensitivity C-reactive protein (hs-CRP) were compared between the two groups. SPSS 26.0 was used for statistical analysis. Data comparison between two groups was performed using t test, χ2test or Fisher′s exact probability method depending on data type. Results A total of 95 patients completed the study, 47 in the intervention group and 48 in the control group. Baseline characteristics showed no statistically significant differences between the two groups (P>0.05). Post-intervention analysis revealed no statistically significant differences between the two groups in nutrient intake, body composition, and safety parameters (P>0.05), and in blood biochemical parameters including liver function, kidney function, blood glucose, and protein indicators (P>0.05). After the intervention, the levels of total cholesterol (TC) [(4.26±1.08) vs (5.79±1.12) mmol/L], low-density lipoprotein cholesterol (LDL-C) [(3.16±0.72) vs (4.45±0.62) mmol/L], non-high-density lipoprotein cholesterol (non-HDL-C) [(3.05±0.82) vs (3.70±0.96) mmol/L], hs-CRP [(0.57±0.23) vs (0.87±0.31) mg/dl], and hs-CRP/HDL-C [(0.47±0.22) vs (0.67±0.25)] in the intervention group were significantly lower than those before the intervention (P<0.05). In the control group, LDL-C was significantly lower after the intervention than before the intervention [(3.52±0.95) vs (4.60±0.58) mmol/L; P<0.05], while non-HDL-C was significantly higher [(4.78±0.63) vs (3.68±1.02) mmol/L; P<0.05]. The intervention group demonstrated significantly lower TG [(1.62±1.11) vs (2.21±1.32) mmol/L], LDL-C [(3.16±0.72) vs (3.52±0.95)mmol/L], non-HDL-C [(3.05±0.82) vs (4.78±0.63) mmol/L], hs-CRP [(0.57±0.23) vs (0.73±0.35)mg/dl], and hs-CRP/HDL-C [(0.47±0.22) vs (0.64±0.36)] than those in the control group (P<0.05). Conclusion Supplementing a stereospecific structured lipid composition improves blood lipid profiles and inflammation in patients with mild hyperlipidemia without adverse effects on hepatorenal function, playing a role in reducing the risk of atherosclerotic cardiovascular diseases.

    参考文献
    相似文献
    引证文献
引用本文

张新胜,魏雨露,吕春健,刘鹿,于志盟,杨荩冉,李丽雅,刘英华.补充立体结构脂质组合物对轻度高脂血症人群血脂干预效果的临床随机对照研究[J].中华老年多器官疾病杂志,2026,25(2):81-86
DOI:10.11915/j. issn.1671-5403.2026.02.019

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-03-11
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-02-03
  • 出版日期:
文章二维码